Sectors

KVUE
Kenvue Inc.
18.76
1 x 18.54
10 x 19.10
bid
ask
-
0.47
2.44%
2 @ 03:59 PM
18.60 -0.16 (0.85%)
Ytd8.75%
1y-14.02%
18.71
day range
19.25
14.02
52 week range
22.87
Open19.10Prev Close19.23Low18.71High19.25Mkt Cap37.40B
Vol12.32MAvg Vol19.69MEPS0.84P/E23.19Forward P/E15.70
Beta0.44Short Ratio2.64Inst. Own94.80%Dividend0.83Div Yield4.26
Ex Div Date05-13Earning08-0650-d Avg17.98200-d Avg17.301yr Est19.58
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-072026-030.270.320.0518.52%
2026-02-172025-120.22N/AN/AN/A
2026-02-172025-120.220.270.0522.73%
2025-11-032025-090.27N/AN/AN/A
2025-11-032025-090.270.280.013.70%
2025-08-072025-060.280.290.013.57%
Upgrade / Downgrade
DateFirmActionFromTo
2026-04-15CitigroupUpgradeNeutralNeutral
2026-04-14BarclaysUpgradeEqual-WeightEqual-Weight
2026-04-07UBSUpgradeNeutralNeutral
2026-03-06BarclaysUpgradeEqual-WeightEqual-Weight
2026-02-18Canaccord GenuityUpgradeHoldHold
2026-02-18CitigroupUpgradeNeutralNeutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2026-03-09ALVARADO LUANIChief Operating Officer61.42KConversion of Exercise of derivative security
2026-03-09LAWSON CARLTONOfficer111.42KConversion of Exercise of derivative security
2025-03-04MEURER JANOfficer33.18KConversion of Exercise of derivative security
2025-03-04MONGON THIBAUTChief Executive Officer216.47KConversion of Exercise of derivative security
2025-12-14PERRY KIRK LChief Executive Officer62.55KConversion of Exercise of derivative security
2025-03-04RUH PAULChief Financial Officer56.20KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2025-12-30Vanguard Group Inc234.95M0.0012.24%
2026-03-30BlackRock Inc145.30M0.007.57%
2026-03-30FMR Inc135.09M0.007.04%
2026-03-30Vanguard Capital Management, LLC124.42M0.006.48%
2026-03-30State Street Corp119.57M0.006.23%
2026-03-30Vanguard Portfolio Management, LLC92.46M0.004.82%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2025-09-29FPA Crescent136.00M0.007.08%
2026-04-29Vanguard Total Stock Mkt Idx Inv61.09M0.003.18%
2026-04-29Vanguard 500 Index Investor49.68M0.002.59%
2026-04-29Vanguard Mid Cap Index Institutional41.50M0.002.16%
2026-05-28iShares Core S&P 500 ETF25.24M0.001.31%
2026-04-29Fidelity 500 Index24.55M0.001.28%
Dividend
DividendDate
0.20752026-05-13
0.20752026-02-11
0.20752025-11-12
0.20752025-08-13
0.2052025-05-14
0.2052025-02-12